Detalles de la búsqueda
1.
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
Lancet
; 397(10273): 499-509, 2021 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33549194
2.
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study.
Clin Exp Rheumatol
; 40(7): 1336-1342, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579092
3.
Bendamustine and rituximab in elderly patients with low-tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study.
Br J Haematol
; 183(1): 76-86, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30117149
4.
Efficiency of autologous stem cell collection: Comparison of three different cell separators.
Transfus Apher Sci
; 56(1): 35-38, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28111240
5.
Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
J Thromb Thrombolysis
; 43(2): 224-232, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28074413
6.
Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms.
Blood
; 120(13): 2650-7, 2012 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22885164
7.
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.
Haematologica
; 98(7): 1107-14, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23645690
8.
Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial.
Haematologica
; 98(11): 1726-31, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23753028
9.
Cryptosporidiosis, an Uncommon Complication after Allogeneic Stem-Cell Transplantation.
Case Rep Oncol
; 16(1): 591-596, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37900815
10.
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.
Lancet
; 377(9759): 42-51, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21176949
11.
Hematopoietic stem cell apheresis in the context of a related allogeneic transplant for acute myeloid leukemia: an unexpected outcome, medical emergency and ethical issue.
Haematologica
; 102(3): e115-e116, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27927773
12.
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study.
J Clin Oncol
; 37(31): 2815-2824, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31339826
13.
Unsuspected FDG-PET findings in the follow-up of patients with lymphoma.
Ann Hematol
; 86(1): 9-15, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17021839
14.
Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study.
Eur J Cancer
; 83: 146-153, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28735072
15.
Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
J Clin Oncol
; 21(23): 4402-6, 2003 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14581437
16.
FDG PET utility in paraneoplastic sweet syndrome.
Clin Nucl Med
; 29(2): 91-2, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14734904
17.
[A-leukemic caecal myeloid sarcoma: a difficult diagnosis]. / Localisation caecale d'un sarcome myéloïde a-leucémique: un diagnostic difficile.
Ann Pathol
; 24(5): 436-9, 2004 Oct.
Artículo
en Francés
| MEDLINE | ID: mdl-15738870
18.
Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma.
Leuk Lymphoma
; 55(4): 773-80, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23927393
19.
Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis.
Hum Pathol
; 45(10): 2085-93, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25149549
20.
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies.
Leuk Res
; 37(9): 1100-6, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23746966